BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37001607)

  • 41. HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study.
    Gilles C; Rozenberg S; Buxant F; Manigart Y; de Wind R; Houte KV; Vandenbroeck D; Delforge M; Konopnicki D
    Vaccine; 2022 Nov; 40(50):7230-7237. PubMed ID: 36328880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
    Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
    Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
    PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of human papillomavirus-based cervical cancer screening strategies in Tanzania among women with and without HIV.
    Kahesa C; Thomsen LT; Linde DS; Mchome B; Katanga J; Swai P; Manongi R; Kjaerem M; Iftner T; Waldstrøm M; Mwaiselage J; Rasch V; Kjaer SK
    Int J Cancer; 2023 Feb; 152(4):686-696. PubMed ID: 36093587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana.
    Castle PE; Varallo JE; Bertram MM; Ratshaa B; Kitheka M; Rammipi K
    PLoS One; 2020; 15(2):e0229086. PubMed ID: 32053659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Facilitators and Barriers to HPV Self-Sampling as a Cervical Cancer Screening Option among Women Living with HIV in Rural Uganda.
    Nyabigambo A; Mayega RW; Hlongwana K; Ginindza TG
    Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297609
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of exposure to polycyclic aromatic hydrocarbons combined with high-risk human papillomavirus infection on cervical intraepithelial neoplasia: A population study in Shanxi Province, China.
    Li X; Ding L; Song L; Gao W; Wang L; Wang J
    Int J Cancer; 2020 May; 146(9):2406-2412. PubMed ID: 31290154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of anal dysplasia and HPV genotypes in gynecology patients: The ANGY cross-sectional prospective clinical study protocol.
    Pache B; Balaya V; Mathis J; Hübner M; Sahli R; Cavassini M; Sempoux C; Mathevet P; Jacot-Guillarmod M
    PLoS One; 2022; 17(10):e0276438. PubMed ID: 36269726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short-term follow up of cervical squamous intraepithelial lesions associated with HIV and human papillomavirus infections in Africa.
    La Ruche G; Leroy V; Mensah-Ado I; Ramon R; You B; Bergeron C; Mothebesoane-Anoh S; Touré-Coulibaly K; Dabis F
    Int J STD AIDS; 1999 Jun; 10(6):363-8. PubMed ID: 10414878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination.
    McClymont E; Lee M; Raboud J; Coutlée F; Walmsley S; Lipsky N; Loutfy M; Trottier S; Smaill F; Klein MB; Harris M; Cohen J; Yudin MH; Wobeser W; Money D
    Int J Gynaecol Obstet; 2020 Jul; 150(1):108-115. PubMed ID: 32342504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.
    Moscicki AB; Ellenberg JH; Vermund SH; Holland CA; Darragh T; Crowley-Nowick PA; Levin L; Wilson CM
    Arch Pediatr Adolesc Med; 2000 Feb; 154(2):127-34. PubMed ID: 10665598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
    Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
    AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV.
    McClymont E; Tan DH; Bondy S; Albert A; Coutlée F; Lee M; Walmsley S; Ogilvie G; Money D
    Int J STD AIDS; 2023 May; 34(6):402-407. PubMed ID: 36702811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human Papillomavirus Infection Among Pregnant Women Living With HIV: A Systematic Review and Meta-Analysis.
    McClymont E; Faber MT; Lindquist S; Bone JN; Kjær SK
    J Acquir Immune Defic Syndr; 2022 Oct; 91(2):122-129. PubMed ID: 36094477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-risk human papillomavirus infection among women living with HIV in Latin America and the Caribbean: A systematic review and meta-analysis.
    Caicedo-Martínez M; Fernández-Deaza G; Ordóñez-Reyes C; Olejua P; Nuche-Berenguer B; Mello MB; Murillo R
    Int J STD AIDS; 2021 Dec; 32(14):1278-1289. PubMed ID: 34488503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A longitudinal study of HPV detection and cervical pathology in HIV infected women.
    Cubie HA; Seagar AL; Beattie GJ; Monaghan S; Williams AR
    Sex Transm Infect; 2000 Aug; 76(4):257-61. PubMed ID: 11026879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and risk factors for human papillomavirus and cervical intraepithelial neoplasia among HIV-positive women at a tertiary level hospital in India.
    Peedicayil A; Thiyagarajan K; Gnanamony M; Pulimood SA; Jeyaseelan V; Kannangai R; Lionel J; Abraham OC; Abraham P
    J Low Genit Tract Dis; 2009 Jul; 13(3):159-64. PubMed ID: 19550213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
    Drolet M; Bénard É; Pérez N; Brisson M;
    Lancet; 2019 Aug; 394(10197):497-509. PubMed ID: 31255301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and correlates of cervical HPV infection in a clinic-based sample of HIV-positive Hispanic women.
    Ortiz AP; Tamayo V; Scorsone A; Soto-Salgado M; Febo I; Piovanetti P; Venegas-Ríos HL; Yamamura Y; Zorrilla C
    Papillomavirus Res; 2017 Dec; 4():39-44. PubMed ID: 29179868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Palefsky JM
    Curr Opin Oncol; 2003 Sep; 15(5):382-8. PubMed ID: 12960521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.